Skip to main content

Pravin Anand and Neeti Wilson look at the workings of intellectual property rights in the life sciences industry.

An in-depth look into the interaction between intellectual property rights and the protection of small molecules , particularly in the pharmaceutical sector, second-generation inventions, DNA, and biological and personalised medicine. The chapter also looks at the intricacies of compulsory licensing, patent infringement and enforcement.

Protection of patent also requires ascertaining ownership and compensation, and the ancillary IP involved in protecting branding and designs.

This chapter was published in IP in the Life Sciences.

To continue reading, please contact us at email@anandandanand.com

Most Recent

News & Insights

VIEW ALL
News & Updates, Thought Leadership
Aug 05, 2026

‘First published on Asia IP’ By: Safir Anand and Ritu Bhargava India has taken important steps forward in protecting consumers who use its digital

Misleading ads and dark patterns: Evolving jurisprudence in India
News & Updates, Thought Leadership
Aug 01, 2026

On 24 May 2024, after roughly a quarter-century of negotiation, the Member States of the World Intellectual Property Organisation adopted, by consensus

WIPO GRATK Treaty: India Helped Write and Would Not Sign
News & Updates, Thought Leadership
Jul 18, 2026

‘First published on India Business Law Journal’ By: Madhu Rewari Artificial intelligence (AI) has changed the internet in both useful and unsettling

Preventing AI-powered domain name abuse
News & Updates, Thought Leadership
Jul 17, 2026

First published by Lexology. Authors: Sandhya Singh and Sampada Kapoor Modern sport is no longer merely an athletic competition; it is a multi-billion-dollar

Managing Ambush Marketing: Legal and Commercial Perspectives